CJC-1295 + Ipamorelin
The CJC-1295 (No DAC) + Ipamorelin Blend combines a synthetic GHRH analogue with a selective ghrelin receptor agonist, investigated in research for synergistic pulsatile growth hormone release and body composition modulation.
Tap I use this — we'll set up your dose, reminders & journey in 30 seconds.
The CJC-1295 (No DAC) + Ipamorelin Blend combines two complementary growth hormone secretagogue peptides commonly studied together for their synergistic effects on the GH axis. CJC-1295 without DAC (Modified GRF 1-29) is a synthetic GHRH analogue that stimulates growth hormone release via the GHRH receptor, while Ipamorelin is a selective ghrelin receptor agonist that promotes GH secretion without significantly affecting cortisol or prolactin levels. Together, they are investigated for amplified, pulsatile GH release in preclinical research models.
- Peptide
- CJC-1295 (No DAC) + Ipamorelin
- Strength
- 10 mg
- Package
- 5mg + 5mg, 10mg + 10mg
- Purity
- 99.81%
- Form
- vial
